SLI

SLI handeln
2.068,07 PKT -2,26 PKT -0,11 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN A0QZBF

ISIN CH0030252883


Analysen zu SLI-Werten

Datum Rating Analyst
02.04.26 UBS Neutral Goldman Sachs Group Inc.
02.04.26 Givaudan Equal Weight Barclays Capital
01.04.26 Richemont Buy Jefferies & Company Inc.
31.03.26 Richemont Sector Perform RBC Capital Markets
31.03.26 Novartis Sell Goldman Sachs Group Inc.
31.03.26 ABB (Asea Brown Boveri) Hold Jefferies & Company Inc.
31.03.26 Givaudan Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
30.03.26 Richemont Buy UBS AG
30.03.26 Novartis Buy Deutsche Bank AG
27.03.26 ABB (Asea Brown Boveri) Market-Perform Bernstein Research
27.03.26 ABB (Asea Brown Boveri) Sell Deutsche Bank AG
27.03.26 Novartis Equal Weight Barclays Capital
27.03.26 Nestlé Equal Weight Barclays Capital
27.03.26 Givaudan Equal Weight Barclays Capital
26.03.26 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
26.03.26 Givaudan Neutral UBS AG
26.03.26 Zurich Insurance Hold Deutsche Bank AG
26.03.26 ABB (Asea Brown Boveri) Market-Perform Bernstein Research
25.03.26 Swiss Re Neutral UBS AG
25.03.26 Nestlé Neutral UBS AG
25.03.26 Richemont Overweight Barclays Capital
25.03.26 Nestlé Hold Deutsche Bank AG
24.03.26 Nestlé Hold Jefferies & Company Inc.
24.03.26 Novartis Buy Deutsche Bank AG
24.03.26 Givaudan Hold Deutsche Bank AG
23.03.26 Richemont Sector Perform RBC Capital Markets
23.03.26 ABB (Asea Brown Boveri) Sector Perform RBC Capital Markets
23.03.26 Novartis Neutral UBS AG
23.03.26 Richemont Overweight JP Morgan Chase & Co.
23.03.26 Swiss Re Underweight Barclays Capital
20.03.26 Novartis Equal Weight Barclays Capital
20.03.26 Novartis Sell Goldman Sachs Group Inc.
19.03.26 ABB (Asea Brown Boveri) Sector Perform RBC Capital Markets
19.03.26 Givaudan Neutral JP Morgan Chase & Co.
18.03.26 Nestlé Sector Perform RBC Capital Markets
18.03.26 Nestlé Neutral JP Morgan Chase & Co.
18.03.26 Givaudan Neutral JP Morgan Chase & Co.
17.03.26 UBS Underweight Barclays Capital
17.03.26 Givaudan Overweight Barclays Capital
17.03.26 Givaudan Neutral UBS AG